Literature DB >> 1703339

Liver transplantation under cyclosporine: a decade of experience.

R D Gordon1, S Todo, A G Tzakis, J J Fung, A Stieber, S M Staschak, S Iwatsuki, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703339      PMCID： PMC3023178     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Orthotopic liver transplantation for alcoholic cirrhosis.

Authors:  T E Starzl; D Van Thiel; A G Tzakis; S Iwatsuki; S Todo; J W Marsh; B Koneru; S Staschak; A Stieber; R D Gordon
Journal:  JAMA       Date:  1988-11-04       Impact factor: 56.272

2.  B hepatitis and liver transplantation.

Authors:  G Ferla; M Colledan; M Doglia; L R Fassati; M Gislon; B Gridelli; G Rossi; D Galmarini
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

4.  TIMY--a center-oriented transplant information management system.

Authors:  B H Markus; S Mitchell; R D Gordon; B Gillquist; A G Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

5.  Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts.

Authors:  W Lauchart; R Müller; R Pichlmayr
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066
  5 in total
  8 in total

1.  Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

Authors:  A Jain; J Reyes; R Kashyap; S F Dodson; A J Demetris; K Ruppert; K Abu-Elmagd; W Marsh; J Madariaga; G Mazariegos; D Geller; C A Bonham; T Gayowski; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  Outcome after Liver Transplantation for Cystic Fibrosis.

Authors:  L A Mieles; D M Orenstein; R M Toussaint; R Selby; R D Gordon; T E Starzl
Journal:  Pediatr Pulmonol Suppl       Date:  1991

3.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.

Authors:  S L Saidman; R J Duquesnoy; A J Demetris; J McCauley; H Ramos; G Mazariegos; R Shapiro; T E Starzl; J J Fung
Journal:  Transpl Immunol       Date:  1994       Impact factor: 1.708

Review 5.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 6.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

7.  Changes in biliary (high-molecular-mass) and liver isoforms of alkaline phosphatase after baboon-to-human liver transplantation.

Authors:  D Mercer; M Tang; I R Marino; A Demetris; J Fung; T Starzl; V Warty
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

8.  Recent advances in hepatic transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; O Bronsther; A Jain; W Irish; H Ramos; I R Marino; F Dodson; R Selby; H Doyle; H Furukawa
Journal:  Clin Transpl       Date:  1993
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.